Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 2/2010

01-04-2010 | Original Article

The Effect of Intraventricular Administration of Nicardipine on Mean Cerebral Blood Flow Velocity Measured by Transcranial Doppler in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Authors: Adam Webb, Jennifer Kolenda, Kathleen Martin, Wendy Wright, Owen Samuels

Published in: Neurocritical Care | Issue 2/2010

Login to get access

Abstract

Background

Cerebral arterial vasospasm and delayed ischemic neurological deficits are significant contributors to morbidity and mortality following aneurysmal subarachnoid hemorrhage. Additional treatment modalities are needed. Intraventricular nicardipine has been suggested as a potential therapy for the treatment of cerebral vasospasm. It is an appealing option for multiple reasons: many of these patients already have ventricular drains in place, it can be safely administered at the bedside, and can be used in patients for whom conventional therapies are either not effective or not tolerated.

Methods

Retrospective case series of all patients who received intraventricular nicardipine for the treatment of cerebral vasospasm from January 2006 to June 2007 at a university tertiary care hospital.

Results

Sixty-four patients received intraventricular nicardipine during the study period. Forty-two patients met inclusion criteria. Intraventricular nicardipine administration was associated with a reduction of the mean cerebral blood flow velocity of 26.3 cm/s in the middle cerebral artery and 7.4 cm/s in the anterior cerebral artery. This reduction was maintained over 24 h with continued administration.

Conclusions

Intraventricular nicardipine was associated with a significant and sustained reduction in mean cerebral blood flow velocity as measured by transcranial Doppler when used in the treatment of suspected cerebral vasospasm following aneurysmal subarachnoid hemorrhage. We do not find significant safety concerns related to elevations of intracranial pressure or ventricular catheter related infections. Further prospective studies are warranted to better determine the efficacy and safety of this therapy.
Literature
1.
Solenski N, Haley E, Kassell N, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study.Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995;23:1007–17.CrossRefPubMed
2.
Kassell N, Torner J, Haley E, Jane J, Adams H, Kongable G. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg. 1990;73:18–36.CrossRefPubMed
3.
Zabramski J, Spetzler R, Bonstelle C. Chronic cerebral vasospasm: effect of calcium antagonists. Neurosurgery. 1986;18:129–35.PubMedCrossRef
4.
Meyer F. Calcium antagonists and vasospasm. Neurosurg Clin N Am. 1990;1:367–76.PubMed
5.
Dorhout Mees S, Rinkel G, Feigin V, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane database of systematic reviews 2007.
6.
Badjatia N, Topcuoglu M, Pryor J, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol. 2004;25:819–26.PubMed
7.
Toyota A, Nishizawa Y. Cerebral vasospasm after subarachnoid hemorrhage, and inhibitory effect of nicardipine investigated by means of TCD ultrasonography. No Shinkei Geka (Neurol Surg). 1991;19:1143–50.
8.
Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir. 1994;131:19–25.CrossRef
9.
Suzuki M, Doi M, Otawara Y, Ogasawara K, Ogawa A. Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev. 2001;24:180–4.CrossRefPubMed
10.
Goodson K, Lapointe M, Monroe T, Chalela J. Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2008;8:247–52.CrossRefPubMed
11.
Ehtisham A, Taylor S, Bayless L, Samuels O, Klein M, Janzen J. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm. South Med J. 2009;102:150–3.PubMed
12.
Kasuya H, Onda H, Takeshita M, Okada Y, Hori T. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke. 2002;33:1011–5.CrossRefPubMed
13.
Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery. 2005;56:895–902.PubMed
14.
Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51:170–81.CrossRefPubMed
15.
Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrahge. a statement for healthcare professionals from a special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.CrossRefPubMed
16.
Treggiari-Venzi M, Suter P, Romand J. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery. 2001;48:49–61.CrossRef
17.
Liu-Deryke X, Rhoney D. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management. Pharmacotherapy. 2006;26:182–203.CrossRefPubMed
18.
Macdonald R, Pluta R, Zhang J. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol. 2007;3:256–63.CrossRefPubMed
19.
Haley E, Kassell N, Torner J. A randomized controlled trial of high-dose intravenous nicardipine in aSAH. A report of the Cooperative Aneurysm Study. J Neurosurg. 1993;78:537–47.CrossRefPubMed
20.
Haley E, Kassell N, Torner J. A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and TCD ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg. 1993;78:548–53.CrossRefPubMed
21.
Weyer G, Nolan C, Macdonald R. Evidence-based cerebral vasospasm management. Neurosurg Focus. 2006;21:1161–70.CrossRef
22.
Voldby B, Petersen O, Buhl M, Jakobsen P, Ostergaard R. Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine). Acta Neurochir. 1984;70:243–54.CrossRef
23.
Gioia A, White R, Bakhtian B, Robertson J. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm. J Neurosurg. 1985;62:721–8.CrossRefPubMed
24.
Kawashima A, Kasuya H, Shiokawa K, Miyajima M, Izawa M, Takakura K. Efficacy of nicardipine prolonged-release pellet on cerebral vasospasm in dogs. No Shinkei Geka (Neurol Surg). 1998;26:37–43.
25.
Eddleman CS, Hurley MC, Naidech AM, Batjer HH, Bendok BR. Endovascular options in the treatment of delayed ischemic neurological deficits due to cerebral vasospasm. Neurosurg Focus. 2009;26:E6.CrossRefPubMed
26.
Komotar RJ, Zacharia BE, Otten ML, Mocco J, Lavine SD. Controversies in the endovascular management of cerebral vasospasm after intracranial aneurysm rupture and future directions for therapeutic approaches. Neurosurgery. 2008;62:897–905.CrossRefPubMed
27.
McGirt MJ, Blessing RP, Goldstein LB. Transcranial Doppler monitoring and clinical decision-making after subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2003;12:88–92.CrossRefPubMed
28.
Suarez JI, Qureshi AI, Yahia AB, et al. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of TCD ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med. 2002;30:1348–55.CrossRefPubMed
29.
Rigamonti A, Ackery A, Baker AJ. TCD monitoring in subarachnoid hemorrhage: a critical tool in critical care. Can J Anaesth. 2008;55:112–23.CrossRefPubMed
30.
Lysakowski C, Walder B, Costanza MC, Tramèr MR. TCD versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke. 2001;32:2292–8.CrossRefPubMed
31.
Grosset DG, Straiton J, du Trevou M, Bullock R. Prediction of symptomatic vasospasm after subarachnoid hemorrhage by rapidly increasing TCD velocity and cerebral blood flow changes. Stroke. 1992;23:674–9.PubMed
32.
Hurst RW, Schnee C, Raps EC, Farber R, Flamm ES. Role of TCD in neuroradiological treatment of intracranial vasospasm. Stroke. 1993;24:299–303.PubMed
33.
Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 1998;88:277–84.CrossRefPubMed
34.
Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med. 1984;310:553–9.PubMed
35.
Lo CH, Spelman D, Bailey M, Cooper DJ, Rosenfeld JV, Brecknell JE. External ventricular drain infections are independent of drain duration: an argument against elective revision. J Neurosurg. 2007;106:378–83.CrossRefPubMed
36.
Frontera JA, Fernandez A, Schmidt JM, et al. Impact of nosocomial infectious complications after subarachnoid hemorrhage. Neurosurgery. 2008;62:80–7.CrossRefPubMed
37.
Korinek A, Reina M, Boch A, Rivera A, De Bels D, Puybasset L. Prevention of external ventricular drain related ventriculitis. Acta Neurochir. 2005;147:39–46.CrossRef
38.
Fujiwara K, Mikawa S, Ebina T. Continuous intrathecal administration of nicardipine using a portable infusion pump system for management of vasospasm after subarachnoid hemorrhage. No Shinkei Geka (Neurol Surg). 2001;29:23–30.
Metadata
Title
The Effect of Intraventricular Administration of Nicardipine on Mean Cerebral Blood Flow Velocity Measured by Transcranial Doppler in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
Authors
Adam Webb
Jennifer Kolenda
Kathleen Martin
Wendy Wright
Owen Samuels
Publication date
01-04-2010
Publisher
Humana Press Inc
Published in
Neurocritical Care / Issue 2/2010
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-009-9307-8

Other articles of this Issue 2/2010

Neurocritical Care 2/2010 Go to the issue

Practical Pearl

Cerebral Vasospasm and Concurrent Left Ventricular Outflow Tract Obstruction: Requirement for Modification of Hyperdynamic Therapy Regimen

Original Article

Ventilator-Associated Pneumonia in a Neurologic Intensive Care Unit Does Not Lead to Increased Mortality

Original Article

Noninvasive Measurement of Cerebral Blood Flow and Blood Oxygenation Using Near-Infrared and Diffuse Correlation Spectroscopies in Critically Brain-Injured Adults

Original Article

Impact of Pattern of Admission on ICH Outcomes

Original Article

CSF Neutrophils Are Implicated in the Development of Vasospasm in Subarachnoid Hemorrhage

Original Article

Intracranial Multimodal Monitoring for Acute Brain Injury: A Single Institution Review of Current Practices